About Stemson Therapeutics
Stemson Therapeutics is a company based in San Diego (United States) founded in 2019 by Geoff Hamilton and Alexey Terskikh.. Stemson Therapeutics has raised $22.5 million across 3 funding rounds from investors including AbbVie, Allergan and DCVC. Stemson Therapeutics operates in a competitive market with competitors including Ardelyx, Blue Rock Therapeutics, DermBiont, Aspen Neuroscience and Inozyme Pharma, among others.
- Headquarter San Diego, United States
- Founders Geoff Hamilton, Alexey Terskikh
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.5 M (USD)
in 3 rounds
-
Latest Funding Round
$15 M (USD), Series A
Jul 16, 2021
-
Investors
AbbVie
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Scientific Team
6 people
Leadership Team
2 people
Co Team
1 people
Research Team
1 people
Scientist Team
1 people
Unlock access to complete
Funding Insights of Stemson Therapeutics
Stemson Therapeutics has successfully raised a total of $22.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $15.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series A - Stemson Therapeutics | Valuation | DCVC | |
| Sep, 2020 | Amount | Seed - Stemson Therapeutics | Valuation | Allergan Aesthetics , Fortunis Capital |
|
| Jun, 2019 | Amount | Seed - Stemson Therapeutics | Valuation | Allergan |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stemson Therapeutics
Stemson Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie, Allergan and DCVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage VC firm focused on life science startups
|
Founded Year | Domain | Location | |
|
Fortunis Capital is engaged in impact-driven venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stemson Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Stemson Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stemson Therapeutics Comparisons
Competitors of Stemson Therapeutics
Stemson Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ardelyx, Blue Rock Therapeutics, DermBiont, Aspen Neuroscience and Inozyme Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of genomic-based personalised pluripotent stem cell therapy
|
|
| domain | founded_year | HQ Location |
Developer of treatments for rare and debilitating metabolic diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stemson Therapeutics
Frequently Asked Questions about Stemson Therapeutics
When was Stemson Therapeutics founded?
Stemson Therapeutics was founded in 2019.
Where is Stemson Therapeutics located?
Stemson Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Stemson Therapeutics?
Geoff Hamilton is the current CEO of Stemson Therapeutics. They have also founded this company.
Is Stemson Therapeutics a funded company?
Stemson Therapeutics is a funded company, having raised a total of $22.5M across 3 funding rounds to date.
What does Stemson Therapeutics do?
Stemson Therapeutics was founded in 2019 in San Diego, United States, within the biotechnology sector. A proprietary platform is utilized to develop stem cell-based therapies for hair growth, focusing on induced pluripotent stem cells (iPSCs) for generating de novo hair follicles and dermal papilla. Operations center on advancing this technology for potential clinical applications in hair restoration.
Who are the top competitors of Stemson Therapeutics?
Stemson Therapeutics's top competitors include Ardelyx, Blue Rock Therapeutics and Aspen Neuroscience.
Who are Stemson Therapeutics's investors?
Stemson Therapeutics has 6 investors. Key investors include AbbVie, Allergan, DCVC, Genoa Ventures, and Allergan Aesthetics.